Kamada (KMDA) Change in Receivables (2012 - 2026)

Kamada (KMDA) posted quarterly Change in Receivables of $1.3 million for Q1 2026, up 291.95% year-on-year from $328611.4 in Q1 2025, and down 70.03% on a QoQ basis from $4.3 million in Q4 2025.

Kamada (KMDA) Change in Receivables (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Change in Receivables for 15 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Receivables rose 291.95% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 174.83% YoY) and the FY2025 annual result came in at -$535000.0, up 72.94% from the prior year.
  • Change in Receivables slipped to $1.3 million in Q1 2026 per KMDA's latest filing, from $4.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for KMDA reached as high as $10.0 million in Q3 2024 and fell as low as -$7.4 million in Q2 2024.
  • A 5-year average of $547165.1 and a median of $6306.0 in 2023 frame the typical range for Change in Receivables.
  • The largest YoY upside for Change in Receivables was 183385.58% in 2023 against a maximum downside of 9620.04% in 2023.
  • Year by year, Change in Receivables stood at -$3141.0 in 2022, then jumped by 183385.58% to $5.8 million in 2023, then plunged by 190.78% to -$5.2 million in 2024, then surged by 182.24% to $4.3 million in 2025, then tumbled by 70.03% to $1.3 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered $1.3 million, $4.3 million, and -$1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 1.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.29 Mn
Mar 31, 2026 1.29 Mn
Dec 31, 2025 4.30 Mn
Dec 31, 2025 4.30 Mn
Sep 30, 2025 -1.04 Mn
Sep 30, 2025 -1.04 Mn
Jun 30, 2025 -2.11 Mn
Jun 30, 2025 -2.11 Mn
Mar 31, 2025 -671,000.00
Mar 31, 2025 -671,000.00
Dec 31, 2024 -5.23 Mn
Dec 31, 2024 -5.23 Mn
Sep 30, 2024 10.00 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 -7.37 Mn
Jun 30, 2024 -7.37 Mn
Mar 31, 2024 610,000.00
Mar 31, 2024 610,000.00
Dec 31, 2023 5.76 Mn
Dec 31, 2023 5.76 Mn